SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (538)5/1/1999 11:41:00 PM
From: Gunter RICHTER   of 4474
 
Yes, you did sneak a peek into the future: a real pharmaceutical company will eventually transform ARIA research into money. Now, since the market knows ARIA can't do it, the game is now to let ARIA bleed to death so it won't have any bargaining power in selling off it's assets.It will all be swallowed up pretty cheap. AND DON'T FORGET THE ACCOUNTING PART OF THE LIQUIDATION EQUATION: there will be so many senior claims pulled out of the drawer against ARIA assets ( salaries,bonuses,research collaboration fees, backdoor agreements with funding partners etc,etc)that common equity will be go virtually unsatisfied. I speak from experience. In the big equity graveyard there are many markers with names like ARIA- and guess what, they all died the same way. No surprise to any sharp mind in the field. Adios Amigo.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News